Skip to main content
Caplight Logo









Orbita

Orbita

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://orbita.ai/

Last Round

Series A

May 28, 2020

Total Funding Raised

$10.5M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Orbita is a healthcare technology company that provides a HIPAA-compliant, conversational AI platform for developing and managing virtual health assistants to improve patient engagement and operational efficiency.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, NLP & Conversational AI, Workflow Automation, EHR & EMR

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

conversational AIpatient engagementhealthcare automationclinical workflow automationelectronic health recordEHRHIPAA compliant AIdigital health assistantAI agentFHIR integrationhealth techpatient triageomnichannel communicationAI guardrailsAI agent security

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orbita Comparables

Compare Orbita with similar companies based on industry and business-model similarity.

Orbita comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hyro
86%
Confido Health
85%
Notable
84%

Orbita Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 28, 2020
SeedApr 30, 2015

Key People

Founding team and executive leadership

Jeff Taylor

Chief Executive Officer

Executive Team

Andrew Eddy

CTO

Executive Team

James Donato

Chief Technology Officer

Executive Team

Orbita Investors

Notable investors and investment history

Orbita investors
InvestorRounds
Newark Venture PartnersSeries A
Philips VenturesSeries A
HealthX VenturesSeries A
Cultivation CapitalSeries A
Newark Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 76% MoM.

  • Jun 17, 2026

    Monthly visitors increased 77% MoM, reaching 12.6K.

Orbita Filings

Explore SEC and related filing metadata, where available.

Orbita filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Orbita's valuation, stock price, and market status.

Is Orbita a public or private company?

Orbita is a private company.

What is the current stock price of Orbita?

Orbita is a private company with no public stock price. No recent secondary market data is available.

How much is Orbita worth (valuation)?

Valuation information for Orbita is not publicly available.

Can I buy Orbita stock?

Orbita shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Orbita's last funding round?

Orbita's most recent funding round was Series A on May 28, 2020.

Who are the main investors in Orbita?

Key investors in Orbita include Philips Ventures, HealthX Ventures.

Will Orbita IPO soon?

No public IPO plans have been announced for Orbita.

How can I track Orbita secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orbita's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range13
Year Founded2015
Last FundingMay 28, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?